feed,title,long_url,short_url
BioRxiv,Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19,https://www.biorxiv.org/content/10.1101/2025.02.26.639208v1?rss=1,https://da.gd/jUh6IK
